These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31824189)

  • 1. Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges.
    Mohannak N; Pattison G; Hird K; Needham M
    Int J Gen Med; 2019; 12():465-474. PubMed ID: 31824189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and Management of Dysphagia in Inflammatory Myopathies.
    Zeng R; Schmidt J
    Curr Rheumatol Rep; 2020 Aug; 22(10):74. PubMed ID: 32860119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.
    Garand KLF; Malandraki GA; Dimachkie MM
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):362-367. PubMed ID: 37678324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis.
    Salam S; Allen J; Dimachkie MM; Hanna MG; Machado PM
    Clin Exp Rheumatol; 2024 Feb; 42(2):425-435. PubMed ID: 38372730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstruction-related dysphagia in inclusion body myositis: Cricopharyngeal bar on videofluoroscopy indicates risk of aspiration.
    Taira K; Yamamoto T; Mori-Yoshimura M; Fujita S; Oya Y; Nishino I; Takahashi Y
    J Neurol Sci; 2020 Jun; 413():116764. PubMed ID: 32172012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing and managing dysphagia in inclusion body myositis: a systematic review.
    Ambrocio KR; Garand KLF; Roy B; Bhutada AM; Malandraki GA
    Rheumatology (Oxford); 2023 Oct; 62(10):3227-3244. PubMed ID: 37115631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis.
    Schrey A; Airas L; Jokela M; Pulkkinen J
    J Neurol Sci; 2017 Sep; 380():142-147. PubMed ID: 28870555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion body myositis: Update on the diagnostic and therapeutic landscape.
    Naddaf E
    Front Neurol; 2022; 13():1020113. PubMed ID: 36237625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphagia in patients with inclusion body myositis.
    Houser SM; Calabrese LH; Strome M
    Laryngoscope; 1998 Jul; 108(7):1001-5. PubMed ID: 9665246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: A pilot study.
    Mohannak N; Pattison G; Radich B; Hird K; Godecke E; Mastaglia F; Needham M
    Neuromuscul Disord; 2020 Apr; 30(4):294-300. PubMed ID: 32307229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of dysphagic inclusion body myositis.
    Taira K; Mori-Yoshimura M; Yamamoto T; Oya Y; Nishino I; Takahashi Y
    Neuromuscul Disord; 2023 Feb; 33(2):133-138. PubMed ID: 36575104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.
    Oh TH; Brumfield KA; Hoskin TL; Stolp KA; Murray JA; Bassford JR
    Mayo Clin Proc; 2007 Apr; 82(4):441-7. PubMed ID: 17418072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dysphagia study in patients with sporadic inclusion body myositis (s-IBM).
    Murata KY; Kouda K; Tajima F; Kondo T
    Neurol Sci; 2012 Aug; 33(4):765-70. PubMed ID: 21993833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysphagia as the Presenting Symptom for Inclusion Body Myositis.
    Esteban MJ; Kassar D; Padilla O; McCallum R
    J Investig Med High Impact Case Rep; 2021; 9():23247096211050211. PubMed ID: 34886694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting dysphagia in inclusion body myositis.
    Cox FM; Verschuuren JJ; Verbist BM; Niks EH; Wintzen AR; Badrising UA
    J Neurol; 2009 Dec; 256(12):2009-13. PubMed ID: 19603245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.
    Lucchini M; Maggi L; Pegoraro E; Filosto M; Rodolico C; Antonini G; Garibaldi M; Valentino ML; Siciliano G; Tasca G; De Arcangelis V; De Fino C; Mirabella M
    Cells; 2021 May; 10(5):. PubMed ID: 34068623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis.
    Ohmura SI; Tamechika SY; Miyamoto T; Kunieda K; Naniwa T
    Int J Rheum Dis; 2022 Aug; 25(8):897-909. PubMed ID: 35678075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies.
    Weihl CC
    Continuum (Minneap Minn); 2019 Dec; 25(6):1586-1598. PubMed ID: 31794461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathies featuring early or prominent dysphagia.
    Triplett JD; Pinto MV; Hosfield EA; Milone M; Liewluck T
    Muscle Nerve; 2020 Sep; 62(3):344-350. PubMed ID: 32510670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.